Earn CME: https://www.naccme.com/program/19-lm-02 In this webcast from the ‘Advances in TKI Therapy for CML: Navigating the Future Treatment Landscape’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Drs. Pinkal Desai and Sangmin Lee debate whether patients in major molecular remission © 2019 Imedex, an HMP Company
Debate: CML in MMR: Should You Stop TKI Treatment?
